Rajesh Krishna, PhD, MBA

Strategic Advisor
Certara

Rajesh Krishna is a global key opinion leader consultant to biotech and pharma companies, and non-profit foundations on biosimulation-enriched strategic new therapeutic development (biologics, conjugated drugs, vaccines, and small molecules). He has contributed to over 20 new medicines throughout his career with a proven track record of product and platform innovations. Retired from the pharmaceutical industry.

Presentation(s):

• Balancing Patient-Centric and Model-Informed Drug Development (MIDD) Approaches to Optimize Dose Selection in Rare Diseases: Are We There Yet?

  Thursday, May 29, 2025
  3:30 PM - 4:30 PM East Coast USA Time